Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Debt (2017 - 2025)

Catheter Precision has reported Non-Current Debt over the past 7 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Non-Current Debt fell 14.8% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 14.8% year-over-year, with the annual reading at $1.3 million for FY2025, 14.8% down from the prior year.
  • Non-Current Debt was $1.3 million for Q4 2025 at Catheter Precision, down from $1.6 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $9.6 million in Q2 2023 and troughed at $1.3 million in Q4 2025.
  • The 3-year median for Non-Current Debt is $8.1 million (2023), against an average of $5.9 million.
  • The largest YoY upside for Non-Current Debt was 14.8% in 2025 against a maximum downside of 14.8% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $8.8 million in 2023, then crashed by 82.36% to $1.6 million in 2024, then decreased by 14.8% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Non-Current Debt are $1.3 million (Q4 2025), $1.6 million (Q4 2024), and $8.8 million (Q3 2023).